Last Updated: June 17, 2026

ZINC SULFATE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Zinc Sulfate, and what generic alternatives are available?

Zinc Sulfate is a drug marketed by Abraxis Pharm, Am Regent, Apotex, Aspiro, Fresenius Kabi Usa, Gland, Nivagen Pharms Inc, Somerset Theraps Llc, Stira, and Zydus Pharms. and is included in ten NDAs.

The generic ingredient in ZINC SULFATE is zinc sulfate. There are thirty-eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the zinc sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Zinc Sulfate

A generic version of ZINC SULFATE was approved as zinc sulfate by AM REGENT on July 18^th, 2019.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for ZINC SULFATE?
What are the global sales for ZINC SULFATE?
What is Average Wholesale Price for ZINC SULFATE?

Summary for ZINC SULFATE

US Patents:	0
Applicants:	10
NDAs:	10

US Patents and Regulatory Information for ZINC SULFATE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abraxis Pharm	ZINC SULFATE	zinc sulfate	INJECTABLE;INJECTION	019229-002	May 5, 1987		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Nivagen Pharms Inc	ZINC SULFATE	zinc sulfate	SOLUTION;INTRAVENOUS	214597-003	Jul 5, 2024	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Zydus Pharms	ZINC SULFATE	zinc sulfate	SOLUTION;INTRAVENOUS	217074-003	Aug 22, 2023	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Aspiro	ZINC SULFATE	zinc sulfate	SOLUTION;INTRAVENOUS	219585-001	May 1, 2025	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Am Regent	ZINC SULFATE	zinc sulfate	SOLUTION;INTRAVENOUS	209377-001	Jul 18, 2019	AP	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.